Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
P/E ratio
27.18 23.16 29.82 31.96

+8 more quarters

P/S ratio
5.29 4.51 5.42 5.98
P/FCF ratio
30.75 29.92 38.51 36.02
P/Operating CF
75.18 117.64 142.97 76.27
P/B ratio
5.30 4.58 5.55 6.17
EV/Sales
5.55 4.68 5.61 6.16
EV/EBITDA
21.42 18.47 22.78 24.24
EV/FCF
32.24 31.06 39.81 37.11
Current Ratio
2.05 2.10 2.07 1.96
Net Debt/EBITDA
3.70 2.67 3.08 2.45
Debt/Equity
0.50 0.43 0.44 0.45
Earnings Yield
3.68% 4.32% 3.35% 3.13%
Free Cash Flow Yield
3.25% 3.34% 2.60% 2.78%
Free Cash Flow per Share
1.56 0.71 0.62 1.59
Book value per Share
26.11 25.26 24.41 23.74
Free Cash Flow
439.00 201.00 175.00 452.00
EV/EBIT
24.96 21.76 27.20 28.96
Other line items

Show all line items

Columns are period end dates